Irfan Tramboo

World Diabetes Day: Young females in Kashmir falling prey to diabetes, say experts

World Diabetes Day: Young females in Kashmir falling prey to diabetes, say experts
Decrease Font Size Increase Font Size Text Size Print This Page

Srinagar: Females below 25 years of age are constituting a majority who have developed diabetes and are registered at Young Diabetes Registry (YDR) at Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura. YDR- SKIMS is one of the regional collaborating centers (RCCs) of the project initiated by the Council of Medical Research (ICMR).

According to the figures that were presented during a function organized on the eve of World Diabetes Day at SKIMS on Wednesday, a total number of 480 patients who are of the age 25 or less than that, have been registered at the YDR. Out of the total number of patients registered at YDR, 59 per cent are females, while as 41 per cent are males.

YDR, being an observational multicentre clinic-based registry enlisting physician-diagnosed diabetes in individuals below 25 years of age, was started by the ICMR in the year 2006, and SKIMS was roped in the year 2015. The registry is currently headed by Prof Shariq Masoodi, Department of Endocrinology SKIMS.

Prof Masoodi in his presentation said that the majority of the patients who are registered with the YDR have been observed to have developed diabetes between the age of 10-25, with females constituting the majority.

“The total number of patients who are registered at YDR is 480, out of which only 286 patients have turned up for the follow-ups, which should have been higher,” he said.

The experts during the function impressed upon the constant consultations of patients with the doctors and effective measures, in terms of diet and medication in order to keep the disease at check.

The YDR at SKIMS is keeping a track over the trend of disease in such patients who are registered, and accordingly conducts survey and researches for better patient care and effective medication. Further, the objectives of the project are to facilitate research in the areas of basic, clinical—including patterns of care and survival—epidemiological, genetic, and molecular levels pertaining to young-onset of diabetes.

During the annual function, it was stated that the average age the patients develop type-1 diabetes is 13 years, whereas, the average age the patients develop type-2 Diabetes is 21. The data is analyzed on the basis of patients registered with the YDR-SKIMS and has been extrapolated similarly.

The experts said that there are greater chances for those, who develop type-2 diabetes, that they might have a family history of the disease, while in case of type-1 diabetes, there are lesser chances that the patient might have a family background of the disease.

“It has been recorded that those who develop type-2 diabetes, 55 per cent had a family history of the disease, while as those who develop type-1 diabetes, 28 per cent of patients said that they had a family history,” Prof Masoodi said.

It was also given out that since the inception of YDR at SKIMS, out of 480 patients, 8 have died so far, which includes three patients who died this year.

The YDR is aimed at addressing the relative scarcity of information on youth-onset diabetes in India, with the major objectives of YDR being to generate information on disease pattern or types of youth-onset diabetes and to estimate the burden of diabetes complications.

The data that was presented during the function stated that in case of patients with diabetes who developed other complication, there are 9.4 per cent of patients who developed renal issues (nephropathy), 5.8 per cent developed complications in their eyes (retinopathy), 5.3 per cent of patients developed neuropathy also known as peripheral neuritis, 1.1 per cent developed cataract, while as 1 per cent developed diabetic foot.

YDR is implemented through regional collaborating centers (RCCs) which coordinate data collection with reporting centers. These centers, it was informed, are tertiary care public centres with a proven track record of conducting multicentre clinical trials and translational research projects in the field of diabetes.

Irfan Tramboo

Irfan Tramboo is a reporter and covers education and health and can be contacted

Leave a Reply

Your email address will not be published. Required fields are marked *